BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.86B |
| 2 |
Rivian
RIVN
|
+$3.55B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$2.79B |
| 4 |
Amazon
AMZN
|
+$2.01B |
| 5 |
Netflix
NFLX
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$2.43B |
| 2 |
KSU
Kansas City Southern
KSU
|
+$1.9B |
| 3 |
NetEase
NTES
|
+$1.73B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.16B |
| 5 |
PayPal
PYPL
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Healthcare | 13.52% |
| 3 | Financials | 12.23% |
| 4 | Consumer Discretionary | 11.23% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
ClearPoint Neuro
CLPT
$389M
| $13.2M | ﹤0.01% |
1,176,355
+12,783
| +1% | +$191K |
|
3477
Village Super Market
VLGEA
$664M
| $13.1M | ﹤0.01% |
561,671
-36,576
| -6% | -$818K |
|
3478
Century Therapeutics
IPSC
$366M
| $13.1M | ﹤0.01% |
827,423
+178,767
| +28% | +$3.36M |
|
|
OMIC
3479
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $13.1M | ﹤0.01% |
37,662
+16,360
| +77% | +$6.34M |
|
3480
Q32 Bio
QTTB
$470M
| $13.1M | ﹤0.01% |
199,321
+6,486
| +3% | +$630K |
|
3481
Angi Inc
ANGI
$250M
| $13.1M | ﹤0.01% |
141,729
-16,503
| -10% | -$1.79M |
|
|
FLG.PRU
3482
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$118M
| $13M | ﹤0.01% |
245,103
+3,005
| +1% | +$159K |
|
3483
Duluth Holdings
DLTH
$161M
| $13M | ﹤0.01% |
853,537
-19,842
| -2% | -$300K |
|
|
FXLV
3484
DELISTED
F45 Training Holdings Inc.
FXLV
| $13M | ﹤0.01% |
1,189,314
+261,959
| +28% | +$3.28M |
|
|
HARP
3485
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $12.9M | ﹤0.01% |
171,433
-1,885
| -1% | -$129K |
|
|
ADVM
3486
DELISTED
Adverum Biotechnologies
ADVM
| $12.9M | ﹤0.01% |
734,682
-8,825
| -1% | -$177K |
|
|
CASA
3487
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $12.9M | ﹤0.01% |
2,278,743
+21,767
| +1% | +$126K |
|
3488
Aldeyra Therapeutics
ALDX
$92.3M
| $12.9M | ﹤0.01% |
3,228,811
-35,131
| -1% | -$268K |
|
3489
Riverview Bancorp
RVSB
$111M
| $12.9M | ﹤0.01% |
1,672,953
+5,060
| +0.3% | +$38.4K |
|
|
EIGR
3490
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $12.8M | ﹤0.01% |
82,432
-39
| -0% | -$7.54K |
|
|
EVLO
3491
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $12.8M | ﹤0.01% |
105,367
+13,354
| +15% | +$2.25M |
|
3492
Afya
AFYA
$1.28B
| $12.7M | ﹤0.01% |
809,067
-135,281
| -14% | -$2.17M |
|
|
DAWN
3493
DELISTED
Day One Biopharmaceuticals
DAWN
| $12.7M | ﹤0.01% |
752,119
+230,846
| +44% | +$4.74M |
|
3494
Tenaris
TS
$29.3B
| $12.6M | ﹤0.01% |
606,165
+33,115
| +6% | +$724K |
|
3495
Pulse Biosciences
PLSE
$2.66B
| $12.6M | ﹤0.01% |
853,126
+10,574
| +1% | +$211K |
|
|
SQZ
3496
DELISTED
SQZ Biotechnologies Company
SQZ
| $12.6M | ﹤0.01% |
1,413,870
+163,780
| +13% | +$2.01M |
|
3497
Tango Therapeutics
TNGX
$4.72B
| $12.6M | ﹤0.01% |
1,152,440
-240,728
| -17% | -$2.89M |
|
|
CSPR
3498
DELISTED
Casper Sleep Inc.
CSPR
| $12.6M | ﹤0.01% |
1,886,694
-100,408
| -5% | -$537K |
|
|
ATHX
3499
DELISTED
Athersys, Inc. Common Stock
ATHX
| $12.6M | ﹤0.01% |
557,309
-22,715
| -4% | -$651K |
|
3500
Tecnoglass Holdings Inc.
TGLS
$2.05B
| $12.6M | ﹤0.01% |
479,838
+79,790
| +20% | +$2.24M |
|
Similar funds
BlackRock's Q4 2021 Portfolio in Review
As of Q4 2021, BlackRock held 5,983 positions worth $3.93T, up 10% from $3.57T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BlackRock's Q4 2021 filing shows 322 new, 3,517 increased, 1,470 reduced and 167 closed positions. Its largest new stake was Rivian: 30,818,728 shares worth $3.2B. The largest sale was JD.com, an estimated $2.43B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2021 buy was Rivian: 30,818,728 shares worth $3.2B.
- BlackRock added most to Microsoft in Q4 2021, an estimated $3.86B increase.
- BlackRock's biggest Q4 2021 reduction was JD.com, cutting an estimated $2.43B.
- BlackRock fully exited Kansas City Southern in Q4 2021, selling an estimated $1.9B.
- BlackRock's ten largest holdings make up 20% of its $3.93T portfolio in Q4 2021.
- BlackRock opened 322 new positions and closed 167 in Q4 2021.
- BlackRock's portfolio value rose 10% quarter-over-quarter to $3.93T.
Based on BlackRock's 13F filing for Q4 2021, filed 10 Feb 2022.